BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16302765)

  • 1. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.
    Sang S; Lee MJ; Hou Z; Ho CT; Yang CS
    J Agric Food Chem; 2005 Nov; 53(24):9478-84. PubMed ID: 16302765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of two forms of methylated (-)-epigallocatechin-3-gallate in green tea.
    Amarowicz R; Shahidi F
    Nahrung; 2003 Feb; 47(1):21-3. PubMed ID: 12653431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.
    Hong J; Lu H; Meng X; Ryu JH; Hara Y; Yang CS
    Cancer Res; 2002 Dec; 62(24):7241-6. PubMed ID: 12499265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic study of the thermal stability of tea catechins in aqueous systems using a microwave reactor.
    Wang R; Zhou W; Wen RA
    J Agric Food Chem; 2006 Aug; 54(16):5924-32. PubMed ID: 16881696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry.
    Mizooku Y; Yoshikawa M; Tsuneyoshi T; Arakawa R
    Rapid Commun Mass Spectrom; 2003; 17(16):1915-8. PubMed ID: 12876693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions.
    Lo CY; Li S; Tan D; Pan MH; Sang S; Ho CT
    Mol Nutr Food Res; 2006 Dec; 50(12):1118-28. PubMed ID: 17103374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
    Williamson MP; McCormick TG; Nance CL; Shearer WT
    J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species.
    Sang S; Shao X; Bai N; Lo CY; Yang CS; Ho CT
    Chem Res Toxicol; 2007 Dec; 20(12):1862-70. PubMed ID: 18001060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets for the cancer preventive activity of tea polyphenols.
    Yang CS; Lambert JD; Hou Z; Ju J; Lu G; Hao X
    Mol Carcinog; 2006 Jun; 45(6):431-5. PubMed ID: 16652355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem mass spectrometry studies of green tea catechins. Identification of three minor components in the polyphenolic extract of green tea.
    Miketova P; Schram KH; Whitney J; Li M; Huang R; Kerns E; Valcic S; Timmermann BN; Rourick R; Klohr S
    J Mass Spectrom; 2000 Jul; 35(7):860-9. PubMed ID: 10934439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel black tea pigment and two new oxidation products of epigallocatechin-3-O-gallate.
    Tanaka T; Matsuo Y; Kouno I
    J Agric Food Chem; 2005 Sep; 53(19):7571-8. PubMed ID: 16159188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
    Weinreb O; Amit T; Youdim MB
    Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals.
    Valcic S; Muders A; Jacobsen NE; Liebler DC; Timmermann BN
    Chem Res Toxicol; 1999 Apr; 12(4):382-6. PubMed ID: 10207128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epimerization of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate: relationship between epimerization and chemical structure.
    Suzuki M; Sano M; Yoshida R; Degawa M; Miyase T; Maeda-Yamamoto M
    J Agric Food Chem; 2003 Jan; 51(2):510-4. PubMed ID: 12517118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma.
    Nakagawa K; Miyazawa T
    Anal Biochem; 1997 May; 248(1):41-9. PubMed ID: 9177723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity.
    Seeram NP; Henning SM; Niu Y; Lee R; Scheuller HS; Heber D
    J Agric Food Chem; 2006 Mar; 54(5):1599-603. PubMed ID: 16506807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.